HEAT BIOLOGICS, INC. HTBX Income Statement

Heat biologics, inc. (HTBX)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Sep'12	Jun'12
Revenue:
Grant and licensing revenue
901	-	-	-	701	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Licensing Revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Grant and licensing revenue
-	-	6	342	-	-	1,840	1,143	752	613	470	411	24	-	220	0	-	-	-	-	-	-	-	-	-	-	-	-	0	3	3
Operating expenses:
Research and development
2,782	3,287	3,129	3,424	3,172	5,476	4,403	3,479	2,872	2,478	1,823	2,151	1,812	2,203	1,693	1,776	3,658	14,898	677	587	503	452	1,025	849	533	616	992	688	440	242	178
Clinical and regulatory
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,718	3,373	2,169	2,129	1,258	1,113	846	649	230	454	62	52	100
General and administrative
3,270	2,229	1,993	1,860	3,347	2,298	1,585	1,361	1,780	2,072	1,188	1,582	1,527	1,203	820	1,083	1,031	1,206	947	893	1,309	1,116	832	1,014	1,014	985	737	438	268	227	360
Goodwill impairment loss
-	-	737	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of contingent consideration
-27	-115	502	112	114	-170	114	539	11	224	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
6,026	5,402	6,361	5,396	6,634	7,604	6,104	5,380	4,664	4,775	3,012	3,734	3,339	3,406	2,513	2,859	4,689	6,842	5,343	4,854	3,982	3,698	3,116	2,977	2,394	2,251	1,960	1,582	770	522	639
Loss from operations
-5,124	-3,403	-6,355	-5,054	-5,933	-5,546	-4,264	-4,237	-3,911	-4,162	-2,541	-3,323	-3,315	-3,285	-2,293	-2,859	-4,689	-6,842	-5,343	-4,854	-3,982	-3,698	-3,116	-2,977	-2,394	-2,251	-1,960	-1,582	-770	-519	-636
Change in fair value of warrant liability
977	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investor relations expense
66	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest income
52	-	-	-	150	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9	-	-	-	-	-	-	-	-	0	0
Interest income
-	-	97	124	-	-	83	44	3	-	5	6	5	-	5	7	11	-	20	20	-	-	9	6	-	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10	9	0	0	0	-	-
Other (expense) income, net
-257	54	-73	-15	8	-35	31	-53	175	-7	31	7	69	-86	734	-57	79	168	4	3	21	15	-12	12	-39	102	-28	-60	10	-	-
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	178	110	123	136	106	108	73	75	32	8	0	0	-21	40	31	28	-	-
Other income (expense)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-
Other expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	61	13
Total non-operating income (loss)
-1,249	113	24	109	159	98	115	-9	178	-3	37	14	74	-258	629	-173	-45	78	-84	-48	-44	-35	-11	19	-28	133	-68	-92	-17	-61	-12
Net loss before income taxes
-	-	-6,330	-4,944	-	-	-4,148	-4,246	-3,733	-	-2,504	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss before income taxes
-6,373	-	-	-	-5,773	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax (expense) benefit
-	0	0	0	45	-320	-225	-235	-205	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-
Net loss
-6,373	-3,289	-6,330	-4,944	-5,819	-5,127	-3,923	-4,011	-3,528	-	-	-3,309	-3,240	-3,543	-1,663	-3,032	-4,734	-6,764	-5,427	-4,902	-4,026	-3,734	-3,127	-2,958	-2,422	-2,117	-2,029	-1,674	-788	-	-
Net loss
-	-	-	-	-	-	-	-	-	-	-2,504	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-788	-580	-648
Loss from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-19
Net Loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-578	-667
Net loss - non-controlling interest
-81	46	-136	-174	-103	-189	-265	-196	-206	-223	-203	-90	-50	-71	-47	-107	-174	-277	-242	-189	-117	-123	-126	-111	-92	-58	-61	-53	-24	-11	-7
Beneficial conversion charge
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-2,300	0	0
Preferred stock dividend
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	361	-	0	-	-
Preferred Stock Dividend
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-
Net loss attributable to Heat Biologics, Inc.
-6,292	-3,336	-6,194	-4,770	-5,715	-4,938	-3,658	-3,815	-3,321	-3,132	-2,300	-3,218	-3,189	-3,472	-1,616	-2,925	-4,559	-6,487	-5,185	-4,713	-3,909	-3,611	-3,000	-2,846	-2,330	-2,059	-2,329	-1,620	-3,063	-567	-659
Net loss per share attributable to Heat Biologics, Inc.-basic and diluted
-0.11	-0.11	-0.18	-0.14	-0.17	0.23	-0.16	-0.26	-0.71	-0.35	-0.64	-0.91	-1.18	-6.40	-0.08	-0.17	-0.50	-0.78	-0.62	-0.56	-0.57	-0.57	-0.46	-0.44	-0.36	0.64	-0.48	-0.92	-1.66	-0.31	-0.38
Weighted-average number of common shares used in net loss per share attributable to Heat Biologics, Inc.-basic and diluted
57,282	32,995	33,650	33,255	33,225	27,360	23,143	14,727	4,709	5,582	3,578	3,524	2,695	-39,034	19,420	17,524	9,124	8,438	8,408	8,401	6,814	6,484	6,469	6,452	6,412	6,531	4,835	1,761	1,859	1,832	1,739
Comprehensive loss
Net loss
-	-	-	-	-	-	-	-	-	-	-2,504	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-6,373	-3,289	-6,330	-4,944	-5,819	-5,127	-3,923	-4,011	-3,528	-	-	-3,309	-3,240	-3,543	-1,663	-3,032	-4,734	-6,764	-5,427	-4,902	-4,026	-3,734	-3,127	-2,958	-2,422	-2,117	-2,029	-1,674	-788	-	-
Unrealized gain (loss) on foreign currency translation
218	-63	63	16	-8	35	39	49	21	6	-24	-9	-66	77	-36	49	-75	-22	-27	-16	-20	0	0	0	0	-	-	-	-	-	-
Total comprehensive loss
-6,154	-3,353	-6,267	-4,928	-5,827	-5,092	-3,884	-3,961	-3,506	-3,348	-2,528	-3,318	-3,307	-3,466	-1,700	-2,983	-4,810	-6,786	-5,454	-4,918	-4,047	-	-3,127	-2,958	-	-	-	-	-	-	-
Total other comprehensive loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,422	-	-	-	-	-	-
Comprehensive loss attributable to non-controlling interest
-81	46	-136	-174	-103	-189	-265	-196	-206	-223	-203	-90	-50	-71	-47	-107	-174	-277	-242	-189	-117	-123	-126	-111	-92	-	-	-	-	-	-
Comprehensive loss - Heat Biologics, Inc.
-6,073	-3,400	-6,130	-4,754	-5,723	-4,902	-3,619	-3,765	-3,300	-3,125	-2,325	-3,228	-3,256	-3,394	-1,653	-2,875	-4,635	-6,509	-5,212	-4,729	-3,930	-3,611	-3,000	-2,846	-2,330	-	-	-	-	-	-